
Patients ‘face NHS rationing' if Labour taxes private healthcare
Experts warn taxing private health insurance premiums would trigger a flood of policy cancellations and push 300,000 patients on to already lengthy hospital waiting lists – potentially delaying elective surgery such as hip replacements by months.
They said that an influx of middle class patients seeking free treatment instead of going private would leave the NHS 'struggling to cope' with extra demand.
Rachel Reeves has not ruled out taxes on private health, which could theoretically raise up to £4bn a year towards filling her budget black hole.
But privately, Whitehall sources have played down the idea and The Telegraph understands it has not been internally discussed within the Government.
Plan 'could raise £2bn a year'
Lord Kinnock, the former Labour leader, last week said that the Government should extend its VAT raid on private schools to health insurance.
He said that the move could raise around £2bn a year, which would provide 'vital funding' for the NHS as it looks to reduce long waiting lists.
However, International Private Medical Insurance (iPMI) Global, the industry body for private healthcare, warned that the policy would backfire.
It said increases in health insurance premiums as providers passed on the VAT would drive an extra 300,000 patients a year on to NHS waiting lists.
'Applying VAT to private healthcare services is expected to significantly increase pressure on the NHS,' the organisation said in a briefing note.
'The higher cost of private care would likely drive many patients, particularly middle-income individuals, back into the public system.
'This influx of patients could worsen already long waiting times for NHS services, increase strain on overstretched NHS staff and facilities, and potentially lead to service rationing or longer delays for elective treatments, as the NHS struggles to cope with increased demand.'
Elective surgery includes operations such as hip and knee replacements for patients who are experiencing discomfort.
iPMI said that middle class families who could not afford significant increases in their health insurance premiums would be 'most significantly affected'.
But wealthy customers who could absorb the cost would not be affected, leading to greater inequality and a 'deeper divide in access to timely healthcare'.
The body also said the move may deter companies from providing private healthcare for their staff, 'further shifting demand back to the NHS'.
Tax 'would increase health care inequality'
Christopher Knight, a global analyst at iPMI, said: 'While applying VAT to private healthcare services may appear equitable and fiscally beneficial, it presents multiple risks.
'These include added strain on NHS services, reduced access for middle-income individuals, administrative challenges, and limited net fiscal gain.'
The Tories also warned that any move to add VAT to private healthcare could lead to NHS patients facing months longer waits for routine operations.
Stuart Andrew, the shadow health secretary, said it would be users of the health service who would suffer most as they were stuck on longer waiting lists.
He said: 'Adding VAT to private healthcare is short-sighted and unfair, hitting ordinary families trying to access timely care where the NHS is failing them.
'This risks patients having to wait months for operations, consultations and life saving treatment. Many of these are middle-income households already under pressure.
'Labour's plan would punish them for going private and add even more strain to overstretched NHS services.
'These health taxes won't fix the NHS, they'll make it worse and as a result of Labour's choices, it will be patients will be paying the price.'
Government battling to hit list targets
Government sources said that Lord Kinnock had not discussed his plan with ministers and acknowledged that it would add to pressure on the NHS.
One added that it was not being seriously considered by the Government at a time when it is battling to hit its targets on reducing hospital waiting lists.
But the Treasury refused to publicly rule out the move, saying that it would not discuss tax measures ahead of the Autumn Budget.
A Government spokesman said: 'Thanks to this government's record investment, reforms and the hard work of NHS staff, we've cut the waiting list by over 260,000 since July 2024, which also fell for the first time in 17 years in April and May outside of the pandemic.
'On top of this, we have also delivered 4.6 million appointments – more than double the 2 million we promised.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
an hour ago
- The Independent
Survey reveals that American kids are skipping school due to anxiety and exhaustion
A recent survey of over 1,000 US parents revealed that nearly a third reported their child missed more than a week of school due to mental health issues. Key reasons for school absence include anxiety, physical symptoms linked to mental health, exhaustion, learning differences, bullying, and concerns about school safety, including gun violence. Since the pandemic, the number of children missing 10 percent or more of school days has almost doubled, affecting over 14 million students in 2021-2022. Experts note that school avoidance, experienced by up to 28 percent of children, is often a symptom of underlying mental health disorders like anxiety or depression. Psychologists advise that allowing children to avoid school due to anxiety can exacerbate the issue, recommending interventions such as talk therapy, medication, and parent-teacher collaboration.


The Independent
an hour ago
- The Independent
Officials urge caution on mosquito bites abroad amid rise in chikungunya cases
Health officials have urged people to take precautions against mosquito bites while on holiday amid a rise in cases of chikungunya among travellers returning from abroad. The UK Health Security Agency (UKHSA) has also detected the first cases of the emerging disease oropouche virus in the UK, all of which were linked to travel from Brazil. Chikungunya is a virus spread by mosquito bites, the symptoms of which include a sudden fever and joint pain. According to UKHSA, most people recover within two weeks, although the joint pain can last for months or even years in some cases. Serious complications are not common, but in rare cases the disease can be fatal, particularly in very young or older people, or those with underlying health conditions. The latest travel-associated infections report from UKHSA shows there were 73 cases of chikungunya reported between January and June 2025, compared to 27 cases for the same period last year. The majority were linked to travel to Sri Lanka, India and Mauritius. All cases were reported in England, primarily in London. There is currently no risk of onward transmission of chikungunya, as the two species of mosquito that transmit the disease are not established in the UK, UKHSA said. The illness mainly occurs in Africa and Asia, specifically southern Asia, although cases have been reported in Europe and parts of North America. However, this year there have been outbreaks in the Americas and Asia, with surges in China and the Indian Ocean islands of Reunion, Mayotte and Mauritius. Dr Philip Veal, consultant in public health at UKHSA, said: 'Chikungunya can be a nasty disease and we're seeing a worrying increase in cases among travellers returning to the UK. 'While this mosquito-borne infection is rarely fatal, it can cause severe joint and muscle pain, headaches, sensitivity to light and skin rashes. Thankfully symptoms usually improve within a few weeks, but joint pain may last for months or longer. 'It is essential to take precautions against mosquito bites when travelling. 'Simple steps, such as using insect repellent, covering up your skin and sleeping under insecticide-treated bed nets can greatly reduce the risk.' Two chikungunya vaccines are approved for use in the UK and are available to buy after an assessment at a private travel clinic. Meanwhile, the first UK cases of oropouche virus, which is spread by midge bites, have been detected by UKHSA. The three cases were all associated with travel to Brazil. The flu-like illness can cause a fever, headaches, joint pain, muscle pain, chills, nausea and vomiting. Officials urged anyone who becomes unwell with these symptoms after travel to affected areas, including parts of Central and South America and the Caribbean, to seek urgent medical advice. According to the World Health Organisation (WHO), before late 2023, oropouche virus was mostly reported near the Amazon rainforest area. However, in 2024, Brazil, Bolivia, Colombia, Cuba, Guyana, Peru and the Dominican Republic reported locally transmitted cases of the disease. The UKHSA report also shows a rise in travel-associated cholera cases in the UK, with eight cases in the first half of the year compared to just one in 2024. Most cases were linked with travel to India and Ethiopia. There was also a 67% decrease in the number of dengue cases reported in England, Wales and Northern Ireland from January to June, and there were just four cases of zika virus during the period, down from nine in 2024.


Daily Mirror
an hour ago
- Daily Mirror
Six Oropouche symptoms easily mistaken for flu after deadly virus first found in UK
UKHSA confirms first UK cases of Oropouche virus in travellers from Brazil. With flu-like symptoms, experts warn holidaymakers to know the signs and take precautions British travellers are being urged to stay vigilant after the UK recorded its first-ever cases of Oropouche virus (OROV), a mosquito and midge-borne infection that can easily be mistaken for the flu. According to the latest UK Health Security Agency (UKHSA) report, three cases of Oropouche were identified in travellers returning from Brazil between January and June 2025. While relatively rare, the virus has been spreading across parts of South and Central America and the Caribbean, with Brazil reporting the largest outbreaks. The infection typically causes high fever, chills, headache, joint pain, and muscle aches - symptoms that closely resemble common viral illnesses, making it easy to misdiagnose. It comes after the NHS warns mouth symptom could be life-shortening disease. READ MORE: Urgent warning issued as dogs and foxes die after eating 'poison' in Devon park Dr Philip Veal, Consultant in Public Health at UKHSA, stressed the importance of taking travel precautions. 'If a person becomes unwell with these symptoms following travel to affected areas, they should seek urgent medical advice,' he said. Pregnant travellers, in particular, are advised to be cautious due to recent concerns about Oropouche virus infection during pregnancy. Symptoms Fever or chills Severe headache Muscle aches or joint pain Nausea or vomiting Rash Diarrhoea Get health warnings straight to your WhatsApp! As the world grapples with the threats of Covid-19, mpox and more, the Mirror has launched its very own Health & Wellbeing WhatsApp community where you'll get health warnings and news straight to your phone. We'll send you the latest breaking updates and exclusives all directly to your phone. Users must download or already have WhatsApp on their phones to join in. All you have to do to join is click on this link, select 'Join Chat' and you're in! We may also send you stories from other titles across the Reach group. We will also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. To leave our community click on the name at the top of your screen and choose Exit group. If you're curious, you can read our Privacy Notice. The rise in Oropouche cases comes alongside other travel-related infections that UKHSA has been tracking. Chikungunya - a mosquito-borne virus causing sudden fever and debilitating joint pain - has seen a sharp increase, with 73 cases reported in England in the first half of 2025. Most affected travellers had returned from Sri Lanka, India, and Mauritius, where outbreaks continue. Although the UK's climate prevents local mosquitoes from transmitting the disease, severe symptoms can linger for months, particularly joint pain, which affects up to 12 percent of patients even three years after infection. For those planning trips to higher-risk regions, two chikungunya vaccines are now available in the UK: IXCHIQ® for adults aged 18 to 59 and Vimkunya® for individuals 12 and older. UKHSA recommended consulting a travel clinic to discuss suitability before travelling. The Travel-associated Infections report also highlights a worrying increase in cholera cases, rising from one case in 2024 to eight in the first half of 2025, largely linked to travel to India and Ethiopia. Dengue and Zika virus cases, by contrast, have fallen, with 161 dengue cases and just four Zika cases reported across England, Wales, and Northern Ireland during the same period. Meningococcal serogroup W (MenW) disease has also been noted among UK travellers, particularly those visiting Saudi Arabia for Umrah and Hajj. The potentially deadly infection can leave survivors with severe lifelong health complications, and vaccination with MenACWY is strongly advised for pilgrims and their close contacts. UKHSA recommends that travellers consult the Travel Health Pro website at least four to six weeks before departure. The site provides comprehensive advice on health risks worldwide, helping travellers take preventive measures such as vaccinations, mosquito bite avoidance, and timely medical guidance if symptoms appear.